Evaluation of sex, race, body mass index and pre-vaccination serum progesterone levels and post-vaccination serum anti-anthrax protective immunoglobulin G on injection site adverse events following anthrax vaccine adsorbed (AVA) in the CDC AVA human clinical trial Tracy Pondo, Centers for Disease Control and Prevention Charles E. Rose, Centers for Disease Control and Prevention Stacey W. Martin, Centers for Disease Control and Prevention Wendy A. Keitel, Baylor College of Medicine Harry L Keyserling, Emory University Janiine Babcock, Walter Reed Army Institute of Research Scott Parker, University of Alabama Birmingham Robert M. Jacobson, Mayo Clinic Gregory A. Poland, Mayo Clinic Michael M McNeil, Centers for Disease Control and Prevention Journal Title: Vaccine Volume: Volume 32, Number 28 Publisher: Elsevier | 2014-06-12, Pages 3548-3554 Type of Work: Article | Post-print: After Peer Review Publisher DOI: 10.1016/j.vaccine.2014.04.025 Permanent URL: https://pid.emory.edu/ark:/25593/s72zb Final published version: http://dx.doi.org/10.1016/j.vaccine.2014.04.025 Copyright information: © 2014 Published by Elsevier Ltd. This is an Open Access work distributed under the terms of the Creative Commons Attribution-NonCommerical-NoDerivs 3.0 Unported License (http://creativecommons.org/licenses/by-nc-nd/3.0/). Accessed December 14, 2021 10:07 PM EST